These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19300081)

  • 1. Interferon and heart disease.
    Angerio AD
    Crit Care Nurs Q; 2009; 32(2):159-62. PubMed ID: 19300081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma: a master regulator of atherosclerosis.
    McLaren JE; Ramji DP
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):125-35. PubMed ID: 19041276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):767-72. PubMed ID: 17479867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine dysregulation in chronic kidney disease: how can we treat it?
    Carrero JJ; Yilmaz MI; Lindholm B; Stenvinkel P
    Blood Purif; 2008; 26(3):291-9. PubMed ID: 18421214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RA patients at high risk for early heart disease. Researchers call for aggressive control of RA disease activity to curb chronic inflammation.
    Health News; 2006 Sep; 12(9):9-10. PubMed ID: 17144015
    [No Abstract]   [Full Text] [Related]  

  • 6. Linking CKD and heart disease.
    Nephrol News Issues; 2005 Mar; 19(4):S1, S8. PubMed ID: 15813312
    [No Abstract]   [Full Text] [Related]  

  • 7. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immune system in atherosclerosis. Immunomodulatory or anti-inflammatory treatment that is effective against atherosclerosis and its complications are needed to ensure the hypothesis].
    Frostegård J
    Lakartidningen; 2013 Oct 23-29; 110(43-44):1931-4. PubMed ID: 24340436
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
    McGill HC; McMahan CA; Gidding SS
    Circulation; 2008 Mar; 117(9):1216-27. PubMed ID: 18316498
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction. Review of major recent findings supporting treatments to control advanced plaques of atherosclerosis.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S1-2. PubMed ID: 19110083
    [No Abstract]   [Full Text] [Related]  

  • 13. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High marks for below-average cholesterol. For the best protection against clogged arteries and heart disease, average cholesterol no longer makes the grade--lower is better.
    Harv Heart Lett; 2006 Feb; 16(6):4-5. PubMed ID: 19662696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The grapefruit-drug interaction debate: role of statins.
    Reamy BV; Stephens MB
    Am Fam Physician; 2007 Jul; 76(2):190, 192; author reply 192. PubMed ID: 17695563
    [No Abstract]   [Full Text] [Related]  

  • 17. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No cancer bonus for statin therapy.
    Harv Heart Lett; 2006 Mar; 16(7):6. PubMed ID: 19663033
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug combinations and all cause mortality in heart disease: use of statins is not supported by study.
    Vos E
    BMJ; 2005 Jul; 331(7509):159; author reply 160. PubMed ID: 16020861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.